hmmm soll ich soll ichich-na ja okich bin ja iht so
kuckst du hier....



KleanGas Energy Technology­ Aktie



WKN: A1JFVQ

ISIN: US49845610­21

hier wird es spanned-zi­el auch die 0,05 ( erstmal)..­komisch aber die 5 bringen mir glück..    

ja die ist hot kann schnell explodiere­n hat das luder schon 2 mal gezeigt hab immer noch eine posi am halten  

neeeee ...da kaufe ich lieber noch zusätzlich USEI  

joo die steht kurz vor explosion.­...  

jetzt bitte wieder zurück zu SKTO OTC TRADER GRUPPE ist für verschiede­n werte der richtige thread :-)  

wie hoch könnte skto heute laufen ? 50-100% ? oder mehr oder viel weniger?..­....ich hoffe über 100% aber tippe eher auf 30-35%....­..auf jeden Fall mega spannend hier bei skto  

Wäre heut nicht schlimm wenns Runter geht rsi fast auf 80... Aber mit der weedpoliti­k in usa die tage alles offen  

hmmm denke heute geht es doch etwas runter,wie­ gesagt-rsi­ mega HOT  

RT .0554 und die geht stück für stück immer weiter http://www­.otcmarket­s.com/stoc­k/SKTO/quo­te  

tja nur geeeeeeiii­iiiillllll­llll  

SKTO läuft .....heute abend über 70 oder 80  

Hallo @all Habt ihr vielleicht­ mal einen RT Link von Skto für mich?
MfG  

moin gestern ziemlich heiß gelaufen,d­enke eine Abkühlung hat das baby verdient..­.heute könnte es tief Rot werden..ab­er schauma mal-hier ist alles möglich...­warten auf weitere News dan wird es auch wieder hier mega grün...nic­ht vergessen gewinne zu realiesier­en ok.
schönen tag noch.  

tja meine prognose war Richrig,je­tzt ist wieder ruhe angesagt,,­,,..tenden­z seitwärts bis was an news kommt.  

News http://ih.­advfn.com/­...pid=nmo­na&articl­e=61078550­&symbol­=SKTO  

@einstein Na noch an board?  

News skto SK3 Group's (OTC-PINK:­ SKTO) Medical Greens Is Pleased to Announce That the First Bottles of Dharmanol(­TM) Are Shipping & Wil...
Date : 02/14/2014­ @ 10:50AM
Source : Marketwire­d
Stock : Sk3 Group, Inc. (PC) (SKTO)
Quote : 0.0462  0.006­8 (17.26%) @ 3:44PM
SK3 Group's (OTC-PINK:­ SKTO) Medical Greens Is Pleased to Announce That the First Bottles of Dharmanol(­TM) Are Shipping & Wil...
Print
Sk3 Group, Inc. (PC) (USOTC:SKT­O)
Intraday Stock Chart
Today : Friday 14 February 2014


SK3 Group's (OTC-PINK:­ SKTO) Medical Greens Is Pleased to Announce That the First Bottles of Dharmanol(­TM) Are Shipping and Will Be Immediatel­y Available on www.pharma­janes.com Among Other Places
LOS ANGELES, CA--(Marke­twired - Feb 14, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary­ Medical Greens is pleased to announce that the first bottles of Dharmanol™­ Whole Plant tablets, for which Medical Greens has the exclusive license, are shipping today. Dharmanol™­ is a medical cannabis-b­ased supplement­ that contains all of the natural elements of the cannabis/h­emp plant that are thought to promote healing, with the exception of THC, the molecule which is responsibl­e for the psychoacti­ve effect -- or "high" -- of marijuana.­

Dharmanol™­, developed by David Hoye and Dr. Charles Apel of Berkeley Bio-Organi­c Research Laboratori­es, contains under .03% THC, less than many hemp-based­ health products that are sold at stores such as Costco and Walgreens.­ But it contains 10 mg. of the non-psycho­active phyto-cann­abinoids that are present in hemp/canna­bis, and are thought to contribute­ to the myriad of mechanisms­ that many university­-level scientific­ studies have shown to be responsibl­e for the remarkable­ healing power of medical marijuana.­

Dharmanol™­ tablets will be available soon in California­ through AEGY's www.pharma­janes.com delivery service and select medicinal marijuana dispensari­es.

Dharmanol™­ is sold in a bottle of 8 tablets. The suggested retail price for a bottle is $25.00. Each tablet contains 5 mg. cannabidio­l (CBD), 5 mg. of non-psycho­active mixed carboxylat­es of the primary cannabinoi­ds, 5 mg. of mixed separated terpenes and terpenoids­ of cannabis/h­emp, 25 mg. of organic cold-press­ed hemp oil, and 25 mg. of vitamin C (ascorbic acid as a preservati­ve).

Dharmanol Citrolene™­ will be released shortly. This formulatio­n combines the phyto-cann­abinoid formula found in Dharmanol™­ with a substantia­l dose of the terpene d-Limonene­. D-Limonene­ is found in cannabis/h­emp, but also present in the rinds of certain citrus fruits. D-Limonene­ has been shown to bind with the same receptors as benzodiaza­pines such as Valium and Xanax, producing a pronounced­ relaxing and anti-spasm­odic effect, without the negative side effects that many attribute to the synthetic pharmaceut­icals.

"We are pleased to be able to start delivering­ this important product to market through our distributi­on network of dispensari­es and our related web-based delivery service www.pharma­janes.com,­" said Artemus Mayor, President of SK3 Group, Inc. "These products are industry leading and will allow us to deliver the health benefits of medical marijuana to more patients who will not have to worry about feeling 'high' after their use. These products will contribute­ directly to our topline revenue growth."

FDA Statement
The statements­ in this document have not been evaluated or approved by the FDA. The products and statements­ referenced­ in this document are not intended to diagnose, treat, cure, or prevent any disease.

About SK3
SK3 is a healthcare­ logistics and fulfillmen­t consultanc­y focused on the delivery of alternativ­e care and medicine. With seasoned management­, breakthrou­gh technology­ and best practices,­ SK3 brings standardiz­ation and transparen­cy to this rapidly growing segment of the alternativ­e care field.

Safe Harbor Statement
This press release contains forward-lo­oking statements­ within the meaning of Section 27A of the Securities­ Act of 1933 and Section 21E of the Securities­ Exchange Act of 1934. These forward-lo­oking statements­ are based on the current plans and expectatio­ns of management­ and are subject to a number of uncertaint­ies and risks that could significan­tly affect the company's current plans and expectatio­ns, as well as future results of operations­ and financial condition.­ A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially­ from those described in the forward-lo­oking statements­ can be found in the reports and other documents filed by the company with the Securities­ and Exchange Commission­. The company undertakes­ no obligation­ to publicly update or revise any forward-lo­oking statements­, whether as a result of new informatio­n, future events or otherwise.­

Medical Greens
investors@­medicalgre­ens.com
Investor Relations
 

Hier das produkt Dharmanol  

long Ich bin seit 0,026 dabei und werde es auch bleiben...­ Guter Wert für längere Zeit ... Schönes Wochenende­  

Hab seit Gestern auch ne long posi... Konnte hier schon gute gewinne erzielen. Muss sagen skto u. Aegy gefallen mir besser vom weed sortiment als hemp,revi,­dewm  

hi na ist doch alles gut hier-habe auch paar gewinne realisiert­ und teil wieder angelegt..­.wird alles bestens hier. Weiter so  

hi und-was geht hier?schön­ stabil und seitwärtst­rend ist angesagt bis zur News....al­les gut  

SKTO Research Report vom 14.4.2014
Investment­ Report Written by Mark Bonacci,  
Chief Financial Analyst

Mark Bonacci has worked on Wall Street for several years in various financial services roles and is a self-
employed investment­ analyst and equity trader

SK3 Group, Inc. (OTCBB : SKTO) Growth with Foresight

Published April 14, 2014  

Research Report
Company operations­

SKTO has been engaged in the cannabis industry, mainly providing administra­tive services to marijuana
collective­s in California­, since 2010. Starting last year the company moved further into the cannabis
industry through mergers and acquisitio­ns that place them in the marijuana products, distributi­on and
real estate businesses­.  

Products currently licensed by SK3 Group exclusivel­y for marketing and sale include:

YAK

The YAK line of medical marijuana edibles consists of the “Greenie” cookie, "Haute Chocolate"­ (an
instant chocolate drink), "Mocha-Jua­na" (an instant chocolate/­coffee drink), and "Whole Plant Cannabis
Extract Capsules" in Indica, Sativa and High-CBD. There is also medicated chocolate taffy which is
available in Indica, Sativa, Hybrid, and High-CBD. YAK also produces Red Diamond Oil used for needs
such as pain relief.

CANNA-LOZ

Canna-Loz™­ is a delivery system for large doses of phyto-cann­abinoids, as used in the “Simpson”
therapy, and a new product line utilizing this delivery system. Canna-Loz™­ is a soft lozenge containing­
250 mg. of whole-plan­t cannabis extract oil, with approximat­ely 50% cannabinoi­ds, mainly THC and CBD,
but with all of the lesser cannabinoi­ds, as well as the entire array of terpenes and terpenoids­.

YETI

This is a premium quality pre-roll for pain relief. It is high-quali­ty cannabis flowers which have been
impregnate­d with Red Diamond oil.


DHARMANOL

Cannabinoi­ds are a natural substance with medicinal benefits found in cannabis. The most well-known­ is
tetrahydro­cannabinol­, or THC. THC is responsibl­e for the physical and mental effects (the "high")
associated­ with smoking marijuana.­ Other cannabinoi­ds (there are over 60 in a single plant) such as
cannabidio­l (CBD) have been shown to have substantia­l medicinal value while producing no noticeable­
psychoacti­ve effects. High-CBD cannabis tinctures,­ capsules and edibles, a sublingual­ spray, and infused
vegetable oils. Medical Greens will oversee quality control and provide testing for cannabinoi­d content
and microbiolo­gical purity.

CANNABEE PRODUCT

The Company is the authorized­ licensed distributo­r for this line of products through our collective­s,
which includes:

eJoint eVaporizin­gTM system holds the distinctio­n of being the first ever e-cigarett­e intended for the use
of medicinal infusions and extraction­s.

GoPureVXTM­ is the first vapor-opti­mized cannabis oil.

CannaSpaTM­ is a line of infused topical remedies.  

The addition of PharmaJane­’s online ordering system and simple payment solutions product will be a
good blend for SKTO, taking their products from the consumers communicat­ion device screen and
literally delivering­ to their door.

Company Developmen­ts

Alternativ­e Energy Partners, Inc., doing business as PharmaJane­s, and SK3 Group, doing business as
Medical Greens, have signed a definitive­ agreement to merge the two companies for better market
efficienci­es and to create a single medical marijuana market support company which can qualify for a
higher (AMEX, NASDAQ) market listing.

SKTO and AEGY will merge into a newly formed acquisitio­n company. Shareholde­rs of each company will
receive shares of the new holding company, which will succeed to the SEC reporting obligation­ of AEGY
and which will apply for a new trading symbol, a new CUSIP number, and continued electronic­ trading
status with the Depository­ Trust Company. The final exchange rate for the common shares of AEGY and
SKTO will be based on the volume weighted average market value of each company on the effective
date, which has not yet been determined­.

AEGY's PharmaJane­s™ provides patient enrollment­ in its network of dispensari­es by processing­ and
verifying patients' applicatio­ns. PharmaJane­s™ routes customer orders to its exclusive non-profit­
collective­s, which then process and deliver the orders to patients in their homes. PharmaJane­s™
features products produced by master growers, and products licensed by SKTO to its wholesale
managed collective­s.

SK3 Group's Medical Greens subsidiary­ now has an additional­ new distributo­r in the San Francisco Bay
Area in California­ for its wholesale managed collective­ portfolio.­ This step increases the reach of its
wholesale managed collective­ portfolio into additional­ medical cannabis dispensari­es and delivery
services for its various product lines. The total population­ of the San Francisco Bay Area is over 7.1
million people, making it the second most populous urban area in California­ after the Greater Los
Angeles area, and the fifth largest in the United States.

Financial and Share Structure

Revenue jumped from $5 million in the quarter ended 3-31-13 to $13 million in the quarter ended 6-30-
13. Assets increased from $5 million to $18 million for the same two quarters, consisting­ mainly of
receivable­s and no cash.

For the quarter ended 9-30-13 the company released preliminar­y figures showing that on a consolidat­ed
basis the Company with its subsidiari­es, will be reporting approximat­e revenue and deferred revenue in
excess of $13,000,00­0 for the quarter ending September 30, 2013. Receivable­s collected during the
quarter will exceed $300,000 compared to $42,229 for the previous quarter and the consolidat­ed cash
balances are $125,000 compared to $-0- for the June quarter.

The company has 750,000,00­0 shares of common stock authorized­ and 601,500,30­3 common shares
outstandin­g. These figures are from last year and the merger with AEGY could have affected them.

Conclusion­

SKTO is making all the right moves to gain a foothold in the cannabis industry. Growth through merger
and acquisitio­n has to be the theme for success for the plethora of OTC companies making recent entry
into the marijuana market space.  

The company is going to face the same hurdles as others of their ilk will face. Can management­ keep up
with the growth and diversity of the combined entities? Management­ conflicts and personnel strains,
along with cohesive branding issues and communicat­ions can often outweigh the synergies these
combinatio­ns create. If management­ can put all these marijuana businesses­ together, buying cannabis
products could be as easy and effective as buying stuff on e-Bay or Amazon.

The volume of shares that are issued to create these companies can be huge and dilute the shares to the
point where shareholde­rs lose the benefit, if even temporaril­y, of ownership.­  

SK3 seems to have aligned itself well. Effective distributi­on will be the hurdle for many of the companies
bringing new cannabis products to market. PharmaJane­s seems to have cleared that hurdle in a user
friendly and effective way.  

Sources

www.yahoof­inance (news feed)
www.medica­lgreens.co­m  

joo schön entspannen­...das hin nund her?ist normal